T
Tessera Therapeutics
tesseratherapeutics.comHeadquarters
United States
Valuation
$2B
Total Funding
$732M
Investors
Regeneron
Description
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and doctors the…